• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    5/15/25 7:10:20 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care
    Get the next $SINT alert in real time by email
    false 0001269026 0001269026 2025-05-15 2025-05-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): May 15, 2025

     

    SINTX Technologies, Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-33624   84-1375299

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    1885 West 2100 South

    Salt Lake City, UT 84119

    (Address of principal executive offices, including Zip Code)

     

    Registrant’s telephone number, including area code: (801) 839-3500

     

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class:   Trading Symbol(s):   Name of each exchange on which registered:
    Common Stock, par value $0.01 per share   SINT   The NASDAQ Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 2.02. Results of Operations and Financial Condition.

     

    On May 15, 2025, SINTX Technologies, Inc. (the “Company”) issued a press release announcing financial results for its quarter ended March 31, 2025 as well as a business update. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K.

     

    The information contained in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section. Furthermore, the information contained in this Item 2.02 or Exhibit 99.1 shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

     

    Item 7.01. Regulation FD. Disclosure.

     

    The information set forth under Item 2.02 is incorporated by reference as if fully set forth herein.

     

    Item 9.01 Financial Statements and Exhibits.

     

    Exhibit No.   Description
    99.1   Press Release, dated May 15, 2025
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        SINTX Technologies, Inc.
           
    Date: May 15, 2025   By: /s/ Eric K. Olson
          Eric K. Olson
          Chief Executive Officer

     

     

     

    Get the next $SINT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SINT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SINT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Anderson Mark Lewis bought $11,800 worth of shares (5,000 units at $2.36) (SEC Form 4)

      4 - Sintx Technologies, Inc. (0001269026) (Issuer)

      5/14/25 7:00:09 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • Chief Strategy Officer Honigblum Gregg R. bought $7,160 worth of shares (4,000 units at $1.79), increasing direct ownership by 40% to 14,000 units (SEC Form 4)

      4 - Sintx Technologies, Inc. (0001269026) (Issuer)

      5/1/25 6:10:49 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • President and CEO Olson Eric K. bought $28,088 worth of shares (14,500 units at $1.94) (SEC Form 4)

      4 - Sintx Technologies, Inc. (0001269026) (Issuer)

      4/30/25 2:25:41 PM ET
      $SINT
      Medical/Dental Instruments
      Health Care

    $SINT
    Leadership Updates

    Live Leadership Updates

    See more
    • SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

      Seasoned Healthcare Executive to Lead Strategic Growth Initiatives Salt Lake City, UT, Nov. 19, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, is pleased to announce the appointment of Gregg R. Honigblum as Chief Strategy Officer (CSO). In this role, Mr. Honigblum will oversee driving corporate strategy to support SINTX's growth initiatives and enhancing investor relations. Mr. Honigblum brings over 35 years of experience as an executive for emerging growth companies, specializing in the healthcare secto

      11/19/24 6:00:00 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care

    $SINT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

      Salt Lake City, UT , May 15, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT), an advanced ceramics company pioneering medical and antipathogenic applications of silicon nitride (Si₃N₄), today provided a comprehensive update on its operational progress, strategic initiatives, and financial position for the first quarter ended March 31, 2025. "We are executing a disciplined transformation that aligns our core capabilities in advanced ceramics with fast-growing, high-impact healthcare applications. This transition positions us for sustainable value creation," said Eric K. Olson, CEO and President of SINTX Technologies. Refocusing on High-Growth Medical Markets SINTX has ac

      5/15/25 7:05:00 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • SINTX Technologies Announces Strategic Changes to Board of Directors

      Company positions for long-term growth in medical device markets Salt Lake City, UT, April 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT), an advanced ceramics company focused on medical device applications, today announced changes to its Board of Directors. The updates reflect the Company's ongoing strategic transformation into a focused medical technology business. Key changes include the retirement of longtime Chairman Dr. B. Sonny Bal, the appointment of President and CEO Eric Olson as Chairman of the Board, and the addition of five new directors with decades of industry expertise spanning orthopedics, spine, interventional pain, cardiovascular, medical device bu

      4/3/25 8:00:00 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • SINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine Fusion

      SALT LAKE CITY, Utah, March 19, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced ceramics for medical device and technical applications, announced today the publication of a new peer-reviewed study demonstrating the biomechanical advantages of silicon nitride in anterior cervical discectomy and fusion (ACDF) procedures. The study, titled Biomechanical Evaluation of Cervical Interbody Fusion Cages for Anterior Cervical Discectomy and Fusion With Variations in Morphology, was conducted by researchers at SRM Institute of Science and Technology in collaboration with SINTX Technologies. Using finite element analysis, the study com

      3/19/25 8:00:00 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care

    $SINT
    SEC Filings

    See more
    • SiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Sintx Technologies, Inc. (0001269026) (Filer)

      5/15/25 7:10:20 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by SiNtx Technologies Inc.

      10-Q - Sintx Technologies, Inc. (0001269026) (Filer)

      5/15/25 7:00:27 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • SiNtx Technologies Inc. filed SEC Form 8-K: Leadership Update

      8-K - Sintx Technologies, Inc. (0001269026) (Filer)

      5/7/25 5:00:15 PM ET
      $SINT
      Medical/Dental Instruments
      Health Care

    $SINT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Anderson Mark Lewis bought $11,800 worth of shares (5,000 units at $2.36) (SEC Form 4)

      4 - Sintx Technologies, Inc. (0001269026) (Issuer)

      5/14/25 7:00:09 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • Chief Strategy Officer Honigblum Gregg R. bought $7,160 worth of shares (4,000 units at $1.79), increasing direct ownership by 40% to 14,000 units (SEC Form 4)

      4 - Sintx Technologies, Inc. (0001269026) (Issuer)

      5/1/25 6:10:49 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • President and CEO Olson Eric K. bought $28,088 worth of shares (14,500 units at $1.94) (SEC Form 4)

      4 - Sintx Technologies, Inc. (0001269026) (Issuer)

      4/30/25 2:25:41 PM ET
      $SINT
      Medical/Dental Instruments
      Health Care

    $SINT
    Financials

    Live finance-specific insights

    See more

    $SINT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SINTX Technologies Acquires Technology Assessment and Transfer, Inc.

      The Acquisition Broadens Opportunities for SINTX in Aerospace, Defense, and Biomedical Markets SALT LAKE CITY, July 06, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, announced the acquisition of Technology Assessment and Transfer, Inc. (TA&T; https://www.techassess.com/), significantly increasing SINTX's capabilities in the aerospace, defense, and biomedical markets. "We are excited to acquire TA&T and take another step towards diversifying and strengthening SINTX," said Dr. Sonny Bal, President and CEO of SINTX. "TA&T will expand our use of advanced manufacturing techno

      7/6/22 9:00:00 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • SINTX Technologies Issues 2022 10-K and Announces Investor Conference Call

      SALT LAKE CITY, March 25, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, announced today the filing of its Annual Report on Form 10-K for the year ended December 31, 2021 with the U.S. Securities and Exchange Commission. In 2021, SINTX made significant investments into the expansion of its three priority business segments - biomedical, industrial/armor, and antipathogenic - through the purchase of new technology, equipment, and personnel. The Company is narrowly focused on opportunities closest to revenue such as armor materials and plates, the development of new biomedi

      3/25/22 5:41:39 PM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • SINTX Technologies Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY

      SALT LAKE CITY, June 30, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, announced today it has moved into the next phase of its relationship with O2TODAY and sold the first shipment of FleX SN-AP antipathogenic silicon nitride powder to O2TODAY for integration into a proprietary line of masks and filters. "O2TODAY announced on its website today that it is taking limited pre-orders for masks and mask filters integrated with SINTX's antipathogenic powder," said Dr. Sonny Bal, President and CEO at SINTX Technologies. "We share th

      6/30/21 9:00:00 AM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by SiNtx Technologies Inc.

      SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

      11/14/24 7:25:52 PM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SiNtx Technologies Inc.

      SC 13G - Sintx Technologies, Inc. (0001269026) (Subject)

      4/1/24 4:17:43 PM ET
      $SINT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by SiNtx Technologies Inc. (Amendment)

      SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

      2/13/24 8:12:54 PM ET
      $SINT
      Medical/Dental Instruments
      Health Care